Archer C, Randhawa M, Kim H, et al. Real world data on intensive follow-up for stage IV metastatic melanoma patients receiving ipilimumab and nivolumab: a safer model of care? SMR 2017, abstract P07-1.
Avelumab versus docetaxel bij gevorderd NSCLC na platinabevattende chemotherapie
jan 2019 | Immuuntherapie, Longoncologie